Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Biocept Inc.
DescriptionBlood based test for EGFR mutations
Molecular Target
Mechanism of Action 
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnose non-small cell lung cancer (NSCLC)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today